Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 44,59
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por National Academies Press, US, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 58,47
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology. Concern about the poor productivity in neuroscience drug development has gained intensity over the past decade, amplified by a retraction in investment from the pharmaceutical industry. This retreat by industry has been fueled by the high failure rate of compounds in advanced clinical trials for nervous system disorders. In response to the de-emphasis of CNS disorders in therapeutic development relative to other disease areas such as cancer, metabolism, and autoimmunity, the National Academies of Sciences, Engineering, and Medicine initiated a series of workshops in 2012 to address the challenges that have slowed drug development for nervous system disorders. Motivated by the notion that advances in genetics and other new technologies are beginning to bring forth new molecular targets and identify new biomarkers, the Academies hosted the third workshop in this series in September 2016.Participants discussed opportunities to accelerate early stages of drug development for nervous system disorders in the absence of animal models that reflect disease and predict efficacy. This publication summarizes the presentations and discussions from the workshop.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 56,14
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 47,23
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Revaluation Books, Exeter, Reino Unido
EUR 50,74
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 94 pages. 13.74x8.94x0.24 inches. In Stock.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 47,18
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 47,74
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 58,70
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback / softback. Condición: New. New copy - Usually dispatched within 3 working days.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 67,86
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 80,37
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Librería: moluna, Greven, Alemania
EUR 49,80
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press Jun 2017, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 53,13
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware - 'A report of the National Academies of Sciences, Engineering, Medicine.'.
Idioma: Inglés
Publicado por National Academies Press, US, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: Rarewaves.com UK, London, Reino Unido
EUR 47,17
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology. Concern about the poor productivity in neuroscience drug development has gained intensity over the past decade, amplified by a retraction in investment from the pharmaceutical industry. This retreat by industry has been fueled by the high failure rate of compounds in advanced clinical trials for nervous system disorders. In response to the de-emphasis of CNS disorders in therapeutic development relative to other disease areas such as cancer, metabolism, and autoimmunity, the National Academies of Sciences, Engineering, and Medicine initiated a series of workshops in 2012 to address the challenges that have slowed drug development for nervous system disorders. Motivated by the notion that advances in genetics and other new technologies are beginning to bring forth new molecular targets and identify new biomarkers, the Academies hosted the third workshop in this series in September 2016.Participants discussed opportunities to accelerate early stages of drug development for nervous system disorders in the absence of animal models that reflect disease and predict efficacy. This publication summarizes the presentations and discussions from the workshop.
Idioma: Inglés
Publicado por National Academies Press, 2017
ISBN 10: 0309455138 ISBN 13: 9780309455138
Librería: preigu, Osnabrück, Alemania
EUR 56,20
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders | Proceedings of a Workshop | Board On Health Sciences Policy (u. a.) | Taschenbuch | Kartoniert / Broschiert | Englisch | 2017 | National Academies Press | EAN 9780309455138 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.